LHrH(GNrH) Agonist Analog Pituitary Suppressants

Luteinizing hormone-releasing hormone (gonadotropin-releasing hormone) agonist analog pituitary suppressants are synthetic peptide derivatives that modulate the hypothalamic-pituitary-gonadal axis

Luteinizing hormone-releasing hormone (gonadotropin-releasing hormone) agonist analog pituitary suppressants are synthetic peptide derivatives that modulate the hypothalamic-pituitary-gonadal axis Consequently, these agents serve as pivotal therapies in hormone-dependent oncology settings such as advanced prostate cancer and premenopausal breast cancer, as well as in benign sex-steroid-dependent disorders including endometriosis, uterine leiomyomas, and central precocious puberty

Although an initial administration induces a transient surge in gonadotropin release, chronic and continuous exposure paradoxically downregulates and desensitizes pituitary receptors, profoundly suppressing luteinizing hormone and follicle-stimulating hormone secretion This reversible inhibition depresses circulating sex hormones to castrate or postmenopausal levels, halting hormone-driven cellular proliferation

Although an initial administration induces a transient surge in gonadotropin release, chronic and continuous exposure paradoxically downregulates and desensitizes pituitary receptors, profoundly suppressing luteinizing hormone and follicle-stimulating hormone secretion

This reversible inhibition depresses circulating sex hormones to castrate or postmenopausal levels, halting hormone-driven cellular proliferation

Consequently, these agents serve as pivotal therapies in hormone-dependent oncology settings such as advanced prostate cancer and premenopausal breast cancer, as well as in benign sex-steroid-dependent disorders including endometriosis, uterine leiomyomas, and central precocious puberty